WARNING:
JavaScript is turned OFF. None of the links on this concept map will
work until it is reactivated.
If you need help turning JavaScript On, click here.
This Concept Map, created with IHMC CmapTools, has information related to: Skin Infection Efficacy Framework - v6, Percent Reduction in Lesion Size >= 20 percent measured at -Entry Visit -48 to 72 hrs from Entry, Change in Route of Administration documented with Reason for Change in Route of Administration, Signs and Symptoms has outcome Failure, Clinical Response has outcome Success, Lesion Size derived from Maximum Length, Resolution of ABSSSI analyzed with ????, Failure documented with Failure Reason, Signs and Symptoms has components ????, Clinical Response assessed from Lesion Size, Signs and Symptoms has outcome Indeterminate, Infection Type has option -Cellulitis/Erycipelas -Major Cutaneous Abscess -Wound Infection, Complications has option -Bacteremia, Failure documented with Failure Reason, Clinical Response has outcome Indeterminate, Percent Reduction in Lesion Size >= 20 percent derived from Clinical Response, Change in Route of Administration documented with Date of Switch, Resolution of ABSSSI measured in -ITT -microITT -Clinically Evaluable -Microbiologically Evaluable, Efficacy Endpoints has components Percent Reduction in Lesion Size >= 20 percent, Percent Reduction in Lesion Size >= 20 percent measured in -ITT -microITT -Clinically Evaluable -Microbiologically Evaluable, -Erythema -Purulent Discharge/Drainage -Non-Purlent Discharge/Drainage -Swelling/Induration -Fluctuance -Tenderness to Palpation -Heat/Localized Warmth -Pain graded as -Absent -Mild -Moderate -Severe